---
figid: PMC3261278__11689_2011_9074_Fig1_HTML
figtitle: Synaptic translation and signaling pathways modulated by FMRP (a) and dysregulation
  of these pathways in the absence or significant reduction of FMRP (b)
organisms:
- Mus musculus
- Rattus norvegicus
- Homo sapiens
- Drosophila melanogaster
- Agaricus bisporus
pmcid: PMC3261278
filename: 11689_2011_9074_Fig1_HTML.jpg
figlink: /pmc/articles/PMC3261278/figure/Fig1/
number: F1
caption: 'Synaptic translation and signaling pathways modulated by FMRP (a) and dysregulation
  of these pathways in the absence or significant reduction of FMRP (b). Shaded areas
  in (b) indicate groups of targets for different strategies aimed at treatment of
  FXS by correcting dysregulated neuronal pathways. Shaded areas are numbered according
  to type of treatment strategy and correspond to numbering system for treatment strategies
  in the text as follows: (1) reduction of activity in pathways that transduce signals
  from group 1 mGluRs or other Gq-linked receptors to the dendritic translational
  machinery via (1a) extracellular pathway (receptor) blockers and/or (1b) intracellular
  pathway blockers; (2) reduction of activity of individual proteins regulated by
  FMRP; (3) increasing surface AMPA receptors and/or activity; (4) modification of
  activity of other receptors/proteins that regulate synaptic activity; and (5) blocking
  translation of mRNAs regulated by FMRP using antisense technology'
papertitle: Targeted treatments for fragile X syndrome.
reftext: Elizabeth Berry-Kravis, et al. J Neurodev Disord. 2011 Sep;3(3):193-210.
year: '2011'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9422606
figid_alias: PMC3261278__F1
figtype: Figure
organisms_ner:
- Drosophila melanogaster
- Mus musculus
- Homo sapiens
- Rattus norvegicus
redirect_from: /figures/PMC3261278__F1
ndex: bc67b737-defc-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3261278__11689_2011_9074_Fig1_HTML.html
  '@type': Dataset
  description: 'Synaptic translation and signaling pathways modulated by FMRP (a)
    and dysregulation of these pathways in the absence or significant reduction of
    FMRP (b). Shaded areas in (b) indicate groups of targets for different strategies
    aimed at treatment of FXS by correcting dysregulated neuronal pathways. Shaded
    areas are numbered according to type of treatment strategy and correspond to numbering
    system for treatment strategies in the text as follows: (1) reduction of activity
    in pathways that transduce signals from group 1 mGluRs or other Gq-linked receptors
    to the dendritic translational machinery via (1a) extracellular pathway (receptor)
    blockers and/or (1b) intracellular pathway blockers; (2) reduction of activity
    of individual proteins regulated by FMRP; (3) increasing surface AMPA receptors
    and/or activity; (4) modification of activity of other receptors/proteins that
    regulate synaptic activity; and (5) blocking translation of mRNAs regulated by
    FMRP using antisense technology'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - GABA-B-R1
  - Rdl
  - Gabat
  - Nmdar1
  - app
  - Appl
  - ApepP
  - APP-BP1
  - Prosap
  - norpA
  - sl
  - Plc21C
  - siz
  - inaC
  - Pkc98E
  - aPKC
  - Pkc53E
  - PEK
  - CaMKII
  - ap
  - dlg2
  - Thor
  - dlg1
  - Dsor1
  - Mtk
  - step
  - Erk7
  - rl
  - eIF4E1
  - eIF4E7
  - eIF4E4
  - eIF4E5
  - eIF4E3
  - eIF4E6
  - eIF4EHP
  - Pka-C1
  - Pka-R2
  - Pka-C3
  - Pka-R1
  - Pka-C2
  - aurA
  - S6KL
  - Fmr1
  - Rac1
  - eEF2
  - homer
  - SLO2
  - La
  - Pink1
  - Arc1
  - Dark
  - .na.character
  - tor
  - Tor
  - Egfr
  - Rac2
  - Akt
  - Mtl
  - sgg
  - wrd
  - wdb
  - mts
  - tws
  - Pp2A-29B
  - App
  - Hspg2
  - Agap2
  - Eif2ak3
  - Camk2a
  - Camk2b
  - Dlg2
  - Mpp2
  - Dlg4
  - Mdk
  - Ptpn5
  - Cilk1
  - Map3k20
  - Ephb2
  - Mapk1
  - Eif4e
  - Mmp9
  - Eef2
  - Npr3
  - Kcnt1
  - Cxcl9
  - Arc
  - Nol3
  - Alpha-re
  - Dmd
  - Stk32c
  - Map3k12
  - Rorc
  - Akt1
  - Gsk3b
  - Ppp2ca
  - Ppp2r1a
  - APP
  - SHANK2
  - HSPG2
  - PLCE1
  - PLCZ1
  - PLCB1
  - PLCB2
  - PLCB3
  - PLCB4
  - PLCD1
  - PLCD3
  - PLCD4
  - PLCG1
  - PLCG2
  - AGAP2
  - PRRT2
  - PRKCA
  - PRKCB
  - PRKCD
  - PRKCE
  - PRKCG
  - PRKCH
  - PRKCI
  - PRKCQ
  - PRKCZ
  - PRKD3
  - EIF2AK3
  - CAMK2G
  - DLG2
  - MPP2
  - DLG4
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - PTPN5
  - CILK1
  - MAP3K20
  - EPHB2
  - MAPK1
  - MAPK3
  - EIF4E
  - EIF4E2
  - EIF4E3
  - PRKAR1A
  - PRKAR1B
  - PRKAR2A
  - PRKAR2B
  - PRKACA
  - PRKACB
  - PRKACG
  - FMR1
  - MMP9
  - EEF2
  - HOMER1
  - HOMER2
  - HOMER3
  - KCNT1
  - CXCL9
  - CMPK1
  - ARC
  - NOL3
  - STK32C
  - NSUN2
  - MAP3K12
  - RORC
  - AKT1
  - RAC1
  - RAC2
  - RAC3
  - RHOG
  - GSK3A
  - GSK3B
  - PTPA
  - Prkcg
  - Camk2d
  - Ephb1
  - GABA
  - AMPA
  - Glutamate
---
